These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15785745)

  • 21. A pilot study of accelerated preoperative hyperfractionated pelvic irradiation with or without low-dose preoperative prophylactic liver irradiation in patients with locally advanced rectal cancer.
    Suwinski R; Wydmanski J; Pawełczyk I; Starzewski J
    Radiother Oncol; 2006 Jul; 80(1):27-32. PubMed ID: 16730087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
    Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival.
    Wiltshire KL; Ward IG; Swallow C; Oza AM; Cummings B; Pond GR; Catton P; Kim J; Ringash J; Wong CS; Wong R; Siu LL; Moore M; Brierley J
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):709-16. PubMed ID: 16242252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for anastomotic leakage after preoperative chemoradiation therapy and low anterior resection with total mesorectal excision for locally advanced rectal cancer.
    Rodríguez-Ramírez SE; Uribe A; Ruiz-García EB; Labastida S; Luna-Pérez P
    Rev Invest Clin; 2006; 58(3):204-10. PubMed ID: 16958295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
    Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC
    Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative morbidity with diversion after low anterior resection in the era of neoadjuvant therapy: a single institution experience.
    Tsikitis VL; Larson DW; Poola VP; Nelson H; Wolff BG; Pemberton JH; Cima RR
    J Am Coll Surg; 2009 Jul; 209(1):114-8. PubMed ID: 19651071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transabdominal transanal resection of distal rectal cancer after high dose preoperative radiotherapy: a Chinese experience in preserving sphincter function.
    Zhou JN; Wang DZ; Huang XE; Xu FP; Shang JQ; Gu RM
    Isr Med Assoc J; 2006 Oct; 8(10):675-8. PubMed ID: 17125111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.
    Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Michalski W; Bebenek M; Kryj M
    Br J Surg; 2006 Oct; 93(10):1215-23. PubMed ID: 16983741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.
    Peeters KC; van de Velde CJ; Leer JW; Martijn H; Junggeburt JM; Kranenbarg EK; Steup WH; Wiggers T; Rutten HJ; Marijnen CA
    J Clin Oncol; 2005 Sep; 23(25):6199-206. PubMed ID: 16135487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
    J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer.
    Movsas B; Diratzouian H; Hanlon A; Cooper H; Freedman G; Konski A; Sigurdson E; Hoffman J; Meropol NJ; Weiner LM; Coia L; Lanciano R; Stein J; Kister D; Eisenberg B
    Am J Clin Oncol; 2006 Oct; 29(5):435-41. PubMed ID: 17023775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
    Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer.
    Krempien R; Roeder F; Oertel S; Roebel M; Weitz J; Hensley FW; Timke C; Funk A; Bischof M; Zabel-Du Bois A; Niethammer AG; Eble MJ; Buchler MW; Treiber M; Debus J
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1143-51. PubMed ID: 16979835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term results after neoadjuvant radiochemotherapy for locally advanced resectable extraperitoneal rectal cancer.
    Coco C; Valentini V; Manno A; Mattana C; Verbo A; Cellini N; Gambacorta MA; Covino M; Mantini G; Miccichè F; Pedretti G; Petito L; Rizzo G; Cosimelli M; Impiombato FA; Picciocchi A
    Dis Colon Rectum; 2006 Mar; 49(3):311-8. PubMed ID: 16456636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermediate dose pre-operative irradiation for carcinoma of the rectum.
    Uno T; Yasuda S; Aruga T; Isobe K; Machida N; Kawakami H; Kawata T; Miyazaki M; Ito H
    Anticancer Res; 2002; 22(5):3013-7. PubMed ID: 12530034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Excision of low rectal carcinomas with sphincter preservation. Multimodal strategy using neoadjuvant radiotherapy and "delayed" coloanal anastomosis without defunctioning stoma].
    Baulieux J; Mabrut JY; Adham M; de La Roche E; Olagne E; Ducerf C; Romestaing P; Gerard JP
    Bull Acad Natl Med; 2004; 188(9):1509-24; discussion 1524-7. PubMed ID: 15997621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: a phase I trial.
    Pfeiffer P
    Acta Oncol; 2005; 44(3):224-9. PubMed ID: 16076693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Postoperative complications of curative treatment for rectal cancer in males with sphincter-preserving total mesorectal excision].
    Szynglarewicz B; Matkowski R; Sydor D; Forgacz J; Pudełko M; Grzebieniak Z
    Pol Merkur Lekarski; 2007 Nov; 23(137):348-51. PubMed ID: 18361317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of intraoperative radiotherapy in locally advanced rectal cancer.
    Ferenschild FT; Vermaas M; Nuyttens JJ; Graveland WJ; Marinelli AW; van der Sijp JR; Wiggers T; Verhoef C; Eggermont AM; de Wilt JH
    Dis Colon Rectum; 2006 Sep; 49(9):1257-65. PubMed ID: 16912909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.